Damage to skin tissue from refractory wounds, surgical procedures and injury represents a growing healthcare need. Shifting demographics will drive industry growth in the years ahead as an aging population provides further stimulus for tissue repair demand. Tissue engineering is now an emerging industry with research and development taking place in the world’s leading universities and companies worldwide. Emerging products and processes for wound management and tissue repair include a number of synthetic and bioengineered products that have recently become available, or are being developed, as adjuncts to wound care and/or as a replacement for human skin.
Bioengineered Skin Substitutes – What You Will Learn
• What are the key segments and patient demographics that comprise the market for engineered skin substitutes?
• What are the major therapeutic demand drivers for bioengineered skin substitutes?
• What are the design factors, material selection issues and technologies that are being used in commercial and development-stage engineered skin substitute products?
• What is the market share and product position in the market?
• Who are the companies behind the current generation of bioengineered skin substitutes and what are their business models?
• What is the role of pharma-device alliances and design partnerships in the commercialization and market access of new and emerging bioengineered skin substitutes?
• What is the impact of economic, technology, and regulatory factors?
Summary of Contents
Advanced Bioengineered Tissue Market Dynamics
Chronic Wounds & Ulcers
Market and Patient Demographics
Factors Limiting Growth
Technology Market Drivers
Bioengineered Skin Substitute Product Analysis
Bilayered Skin Substitutes
Non-FDA Cleared Skin Substitutes
Cultured Epidermal Autografts
Market Sector Data, Assessments & Forecasts
Business Sector Strategies and Risks
Strategic Alliances & Partnerships
Development Stage Transition Factors
Clinical Trial Factors
Evolving Patient Demographics
Protocols and End-Points